Open Access

Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells

  • Authors:
    • Xueqin Pang
    • Rui Li
    • Dongtao Shi
    • Xudong Pan
    • Chen Ma
    • Guangbo Zhang
    • Chuanyong Mu
    • Weichang Chen
  • View Affiliations

  • Published online on: October 13, 2017     https://doi.org/10.3892/ol.2017.7182
  • Pages:8028-8034
  • Copyright: © Pang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: PDF 0 views | HTML 0 views
0

Abstract

Colon cancer is one of the most common malignant tumors in the human body, ranking second as a gastrointestinal tumor. It has a high incidence in Europe, America and China and more than 1 million new cases of colon cancer are reported worldwide each year. The incidence of colon cancer in China has increased from 12/0.1 million in the early 1970s to 56/0.1 million at present with an annual growth rate of 4.2%, which far exceeds the international level (2%). Rhotekin (RTKN) 2, a Rho-guanosine triphosphatase (GTPase) effector, has been reported to be anti-apoptotic. However, the molecular mechanism underlying the biological function of RTKN2 in colon cancer remains unknown. The present study investigated whether the mRNA expression level of RTKN2 was markedly higher in 30 human colon cancer specimens compared with adjacent non-cancerous tissues. The results showed that the protein expression level of RTKN2 was significantly higher in SW480 and HCT116 cells, compared with HIEC cells. Knockdown of RTKN2 in the SW480 and HCT116 colon cancer cells, by lentivirus-mediated RNA interference led to the notable inhibition of cell proliferation and cell cycle progression, by reducing the expression levels of the PCDA, Cyclin D1 and c-myc cell cycle-associated proteins. The inhibitory effect of RTKN2 silencing on the proliferation of colon cancer cells may be partially realized by inhibiting the Wnt/β-catenin signaling pathway. Furthermore, the silencing of RTKN2 in the cells induced apoptosis by reducing the expression level of Bax and increasing the expression level of Bcl2. These results show that RTKN2 is involved in the carcinogenesis and progression of human colon cancer, indicating that RTKN2 may be a molecular target in colon cancer therapy.

Related Articles

Journal Cover

December 2017
Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Pang, X., Li, R., Shi, D., Pan, X., Ma, C., Zhang, G. ... Chen, W. (2017). Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells. Oncology Letters, 14, 8028-8034. https://doi.org/10.3892/ol.2017.7182
MLA
Pang, X., Li, R., Shi, D., Pan, X., Ma, C., Zhang, G., Mu, C., Chen, W."Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells". Oncology Letters 14.6 (2017): 8028-8034.
Chicago
Pang, X., Li, R., Shi, D., Pan, X., Ma, C., Zhang, G., Mu, C., Chen, W."Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells". Oncology Letters 14, no. 6 (2017): 8028-8034. https://doi.org/10.3892/ol.2017.7182